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Acute blunt traumatic injury to the descending
thoracic aorta
Paul J. Riesenman, MD, MS, James D. Brooks, BS, and Mark A. Farber, MD, Chapel Hill, NC
Introduction: Blunt injury to the descending thoracic aorta is a potentially life-threatening condition necessitating rapid
assessment and possible surgical intervention. The purpose of this study was to review outcomes of patients who sustained
blunt thoracic aortic injury at a single institution.
Methods: Our institutional Trauma Registry Database was searched for patients who sustained acute blunt descending
thoracic aortic injury between July 1990 and July 2010. Individual injuries, anatomic and physiological measures of
injury severity, and operative and hospital mortality were compared between patients undergoing open surgical and
thoracic endovascular aortic repair. Additionally, aortic injury grade, management, and outcomes were reviewed for
patients who did not undergo an aortic intervention.
Results: Of the 100 patients identified over the 20-year study period, 60 (60%) underwent conventional open repair, 26
(26%) underwent endovascular repair, and 14 (14%) did not undergo an aortic intervention. The overall hospital
mortality rate for the entire patient cohort was 34%. Of the 14 patients who did not undergo an aortic intervention, five
(36%) were successfully medically managed and four (80%) of these had grade I aortic injuries. One of the successfully
medically managed patients required endovascular repair 9 months after injury. Four medically managed patients expired
as a result of aortic rupture within 1 to 2.5 hours of presentation. Two expired immediately after diagnosis, and the other
two could have potentially been treated with improvements in transfer and diagnosis times. Age, individual injuries, and
measures of injury severity were similar between patients undergoing open surgical or endovascular repair. Patients who
underwent endovascular repair experienced a significantly lower intraoperative (0% vs 18%; P < .05) and overall hospital
mortality (12% vs 37%; P < .05). Additionally, endovascular repair was associated with reductions in operative time,
estimated blood loss, and intraoperative blood transfusions. Five endovascular patients required secondary interventions
to treat endograft-related complications, including malapposition to the aortic arch (n  3), midendograft stenosis (n 
1), and left upper extremity ischemia (n  1).
Conclusions: Blunt thoracic aortic injury to the descending thoracic aorta is associated with a high overall hospital
mortality. Thoracic endovascular aortic repair is associated with significantly lower operative times, procedural blood
loss, intraoperative blood transfusion, as well as intraoperative and overall hospital mortality compared with conventional
open surgical repair. Consideration of this form of therapy as the initial form of treatment is warranted in anatomically
acceptable candidates. ( J Vasc Surg 2012;56:1274-80.)
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MThe management and treatment of acute blunt tho-
racic aortic injuries (TAIs) has undergone several devel-
opments since the landmark paper by Parmley et al in
1958 detailing the lethality of this condition.1 Since that
time, progressive advancements in cardiothoracic sur-
gery, surgical critical care, diagnostic imaging, and non-
operative management have significantly improved the
morbidity and mortality associated with this injury. The
application of a handmade endograft to treat an acute
TAI was first reported by Semba et al in 1997,2 and
today, thoracic endovascular aortic repair (TEVAR) is
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1274egarded as the next technical advancement that may
mprove outcomes associated with this condition.3,4
Early encouraging results using a variety of en-
ografts,5 as well as increasing availability and experience
ith commercially manufactured thoracic devices,6 has
ontributed to the rapid adoption of this treatment modal-
ty for acute TAIs. Indeed, several institutions have re-
orted a relatively abrupt transition from open surgical
epair to TEVAR as the primary form of intervention for
his condition.7,8 Additionally, in the United States, re-
orts from multicenter and nationwide databases suggest
hat TEVAR of acute TAIs has now surpassed conventional
pen surgery as the most common form of treatment at the
ational level.4,9 This rapid adoption of TEVAR, and the
orresponding reduction in open surgical volume for these
njuries, has limited the opportunities for comparative anal-
ses of this relatively rare condition. The purpose of this
tudy was to review the management and outcomes of
atients presenting to our institution with acute blunt TAIs
o the descending thoracic aorta.
ETHODS
Institutional Review Board approval was obtained for
he review of all patient records. From July 1990 through
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Volume 56, Number 5 Riesenman et al 1275July 2010, the University of North Carolina Hospital’s
Trauma Registry Database was searched for International
Classification of Diseases Version 9 codes 901.0 Injury
aorta (thoracic) and 902.0 Injury aorta (abdominal). Iden-
tified patients underwent a review of electronic and paper
records, as well as available imaging studies. Only patients
who sustained acute blunt traumatic TAIs to the descend-
ing thoracic aorta (distal to the left subclavian artery) were
included for further analysis. Injury Severity Score (ISS)10
and New Injury Severity Score (NISS)11 were obtained
from the Trauma Registry. Revised Trauma Score (RTS)
was calculated based on data obtained from review of
medical records.12 Classification of aortic injuries was as
previously described13 and based on review of available
computed tomographic (CT) imaging studies.
Aortic procedures performed within 14 days of injury
were defined as acute interventions. For patients who un-
derwent TEVAR, evaluation, device selection, and proce-
dural details were as previously described.14 Open surgical
intervention was considered to have been performed if the
patient presented to the operating room and underwent a
thoracotomy with the intention of repairing the TAI. The
techniques for open surgical repair have been previously
described.15
Data analysis was performed with the use of StatView
Table I. Patient characteristics: endovascular, open surgic
Value TEVAR
N 26 (26%)
Age, years (mean) 40.0  19.9
Male 19 (73%)
White 14 (54%)
Transferred 20 (77%)
Etiology
Motor vehicle collision 16 (62%)
Motorcycle collision 7 (27%)
Pedestrian hit by car 0 (0%)
Fall 3 (12%)
Other 0 (0%)
Location of aortic injury
Isthmus 24 (92%)
Distal thoracic aorta 2 (8%)
Measures of traumatic injury
Revised Trauma Score 6.612  1.496a
Injury Severity Score 39  12
New Injury Severity Score 46  14
Associated traumatic injuries
Head injury 10 (38%)
Lung injury 18 (69%)
Abdominal injury 16 (62%)
Pelvic fracture 10 (38%)
Long bone fracture 8 (31%)
Rib fractures 16 (62%)
Clavicle fracture 3 (12%)
Scapula fracture 1 (4%)
Sternal fracture 4 (15%)
Neurologic deficits 3 (12%)
Unstable spine fractures 6 (23%)
TEVAR, Thoracic endovascular aortic repair.
an  24; initial Glasgow Coma Scale and vital sign data not available on tw(SAS Institute, Cary, NC). Group data are expressed as the Iean  standard deviation. Population proportions were
ompared using Fisher’s exact test. Two-tailed P values are
eported. Student’s t-test was used to compare continuous
ariables. Comparisons between groups were considered
tatistically significant if P  .05.
ESULTS
During the 20-year study period, a total of 100 patients
ere identified who presented with acute blunt TAIs to the
escending thoracic aorta. Of these, 60 (60%) underwent
pen surgical intervention, 26 (26%) underwent TEVAR,
nd 14 (14%) did not undergo an intervention during the
nitial hospitalization for their injury. Patient characteristics
f open surgical, endovascular, nonintervention, and the
verall patient cohort are presented in Table I. In compar-
ng open surgical and endovascular groups, there was no
tatistically significant difference in terms of age, gender,
ace, proportion presenting as transfers from another insti-
ution, etiology of injury, aortic injury location, physiolog-
cal (RTS) or anatomic (ISS and NISS) measures of injury
everity, and individual associated injuries (all P  .05). In
otal, 58 patients had presenting CT imaging of the chest
vailable for review (Table II). The 30-day hospital mortal-
ty based on thoracic aortic injury classification for these 58
atients was grade I 0% (0/3), grade II 29% (2/7), grade
d nonintervention
Open Nonintervention Overall
60 (60%) 14 (14%) 100
8.8  19.9 41.4  22.5 39.5  20.1
43 (72%) 6 (43%) 68 (68%)
44 (73%) 8 (57%) 66 (66%)
35 (58%) 8 (57%) 63 (63%)
48 (80%) 9 (64%) 73 (73%)
6 (10%) 3 (21%) 16 (16%)
3 (5%) 2 (14%) 5 (5%)
1 (2%) 0 (0%) 4 (4%)
2 (3%) 0 (0%) 2 (2%)
57 (95%) 14 (100%) 95 (95%)
3 (5%) 0 (0%) 5 (5%)
75  1.202 5.886  1.885 6.792  1.436
40  14 36  12 39  13
47  13 42  15 46  13
14 (23%) 6 (43%) 30 (30%)
46 (77%) 8 (57%) 72 (72%)
29 (48%) 9 (64%) 54 (54%)
35 (58%) 5 (36%) 50 (50%)
22 (37%) 4 (29%) 34 (34%)
38 (63%) 6 (43%) 60 (60%)
6 (10%) 1 (7%) 10 (10%)
4 (7%) 1 (7%) 6 (6%)
2 (3%) 0 (0%) 6 (6%)
4 (7%) 0 (0%) 7 (7%)
5 (8%) 1 (7%) 12 (12%)
AR patients.al, an
3
7.0II 26% (11/43), and grade IV 60% (3/5). All patients
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November 20121276 Riesenman et alclassified into the TEVAR and open surgical groups under-
went intervention for their aortic injury within 14 days of
the traumatic event.
Among the 14 patients who did not receive an inter-
vention, five died from other associated traumatic injuries
with the majority of these patients (four of five) expiring
within 24 hours of injury. An additional four patients died
from aortic rupture; all had grade III or IV injuries. Two of
these patients died in the emergency department at 1 and
1.3 hours from their initial presentation to our institution.
Both became unstable immediately after CT scan evalua-
tion. One patient died in the intensive care unit after
experiencing a delay in transfer to our facility (1.5 hours
from presentation but 8 hours from the time of injury).
Finally, one patient expired in the operating room holding
area during an unintentional delay to operative interven-
tion (2.5 hours from presentation; 3.2 hours from injury).
An additional five patients were successfully managed non-
operatively and discharged home; all had grade I (n 4) or
II (n  1) injuries. One patient with a grade I injury
demonstrated complete resolution of the aortic injury on
repeat imaging at 2 weeks. Another patient with a grade I
injury developed a pseudoaneurysm on imaging performed
at 6 months, and subsequently underwent successful
TEVAR at 9 months. The remaining three patients demon-
strated stability of their aortic injuries on follow-up CT scans
performed between 3 and 18 months posttrauma.
Due to a lack of appropriately configured commercially
manufactured thoracic endografts early in our experience,
abdominal aortic endograft components were utilized in
eight (31%) patients. Abdominal components included
Gore Excluder Aortic Extender cuffs (n 5; W. L. Gore &
Associates Inc, Flagstaff, Ariz), Zenith AAA endovascular
graft iliac leg extensions (n  2; Cook Inc, Bloomington,
Ind), and a Vanguard Endovascular Aortic Graft Cuff (n
1; Boston Scientific, Natick, Mass). Commercially manu-
factured thoracic endografts were placed in the remaining
18 (69%) patients and included the TAG (n  8; W. L.
Gore & Associates Inc) endoprosthesis, Talent Thoracic
(n  5; Medtronic AVE, Santa Rosa, Calif), conformable
TAG (CTAG; n 2;W. L. Gore&Associates Inc), and the
Zenith TX2 TAA Endovascular Graft (n  2; Cook Inc).
Additionally, one patient received both a TAG and a Talent
device at the time of the primary intervention. In this
patient, the TAG device was initially deployed but dis-
played malapposition to the inner curvature of the distal
aortic arch. The Talent device was deployed within the
TAG component to increase the radial force, successfully
Table II. Thoracic aortic injury grade
Value n I II III IV
Thoracic endovascular aortic repair 20 0 2 17 1
Open surgery 26 0 3 21 2
Nonintervention 12 3 2 5 2
Total 58 3 7 43 5resolving the malapposition. Fourteen of the thoracic en- uografts were placed as emergent off-label applications and
our devices (two Talent and two CTAG) were placed as
art of Food and Drug Administration-approved clinical
nvestigative protocols. Primary technical success resulting
n successful deployment and exclusion of the aortic injury
Fig 1, A and B) was obtained in all patients. Six (23%)
EVAR patients did not receive intraoperative systemic hep-
rin during the procedure due to concern for exacerbating
oncomitant traumatic injuries, and none sustained thrombo-
mbolic complications. It has been our institutional practice
o forgo heparinization, or administer a reduced dose in
atients undergoing TEVAR with associated traumatic inju-
ies. Additionally, it is not our practice to routinely initiate
ntiplatelet therapy in patients who have undergone TEVAR
or acute TAIs and chemical deep venous thrombosis prophy-
axis is routinely initiated, or contraindicated in the context of
ssociated traumatic injuries.
For the open surgical patients, 50 (83%) underwent left
eart bypass, four (7%) underwent clamp-and-sew tech-
ique, and five (8%) underwent aortic cross-clamping but
ied prior to completion of the repair. One patient could
ot tolerate single-lung ventilation and the procedure was
erminated shortly after operative exposure. The mean
ortic cross-clamp time was 57  23 minutes.
Operative data of TEVAR and open surgical patients is
resented in Table III. The mean time from injury to inter-
ention and in-hospital delay was not significantly different.
atients who underwent TEVAR had a significantly shorter
perative time, experienced less reported blood loss, received
ess intraoperative units of allogenic blood, andwere less likely
o experience intraoperative mortality. In comparing hospital
utcomes, intensive care unit and overall hospital length of
tay were not significantly different between TEVAR and
pen surgical operative survivors (Table IV). None of the
pecific categorical complications reached significance be-
ween the two groups. Three patients in the open surgical
roup developed postoperative paralysis/paraparesis. One pa-
ient sustained lower extremity paraparesis following repair
ith left heart bypass, and two patients sustained permanent
ower extremity paralysis following repair with the clamp-and-
ew technique. The reported cross-clamp times for these two
atients were 67 and 36minutes. Three TEVAR patients and
n additional 11 open surgical patients died within 30 days of
heir intervention. The overall hospital mortality for all pa-
ients (n100) presentingwith acute bluntTAIwas 34% and
as significantly greater for patients who underwent open
urgical intervention compared with TEVAR (37% vs 12%;
 .021).
No cases of device migration or endoleak (perfusion of
ny residual aneurysmal defect at the site of injury) were
etected among TEVAR patients during a mean follow-up of
5.8 months. Five of these patients (19%) required a total of
ix secondary interventions. Three patients experienced
alapposition to the inner curvature of the distal aortic arch.
ll were detected within 2 weeks of TEVAR. One was suc-
essfully treated with balloon angioplasty of the proximal
ndoprosthesis. Another underwent balloon angioplasty and
ltimately required a Palmaz stent (Johnson & Johnson,
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Volume 56, Number 5 Riesenman et al 1277Warren, NJ) to resolve the malapposition. This case has been
previously reported in detail.16 The final patient had received
a TAGdevice that was deployed successfully at the time of the
primary procedure but was found to be malapposed on post-
operative day 3. This patient was treated with a Talent device
in a similar fashion to our other patient who experienced the
same complication at the time of their primary intervention.
Another patient received a left subclavian artery stent due to
Fig 1. Intraoperative angiogram during thoracic endo
sustaining a blunt thoracic aortic injury.A,Active extrava
endograft deployment with a Talent Thoracic stent graft
Table III. Operative data: endovascular and open repair
Value TEVAR Open P
N 26 60
In-hospital delay
(minutes)a 445  513 520  1957 .849
Range 0-2163 14-14,204
Injury to intervention
(minutes)b 2448  4780c 1325  3016 .242
Range 202-19,952 121-16,054
Operative data
Mean operative time
(minutes) 105  33 216  92 .001
Mean estimated
blood loss (mL) 76  39 2833  3573d .001
Number patients
transfused 13 (50%) 53 (88%) .001
Mean blood
transfusion (units) 1.3  1.8 6.0  5.0 .001
Intraoperative blood
salvage 0 (0%) 44 (73%) .001
Systemic heparin 20 (77%) 34 (57%) .092
Intraoperative death 0 (0%) 11 (18%) .030
TEVAR, Thoracic endovascular aortic repair.
aTime of arrival for patients with known aortic injury or time of diagnosis at
our institution, to time of presentation to the operating room.
bTime of injury to time of presentation to the operating room.
cn  24; time of injury data incomplete on two TEVAR patients.
dn  56; blood loss not reported on four open surgical patients.concern for extremity ischemia following coverage of this ressel by the endograft. Following TEVAR, the patient was
ound to have a cool extremity with a monophasic left radial
rtery signal, and a neurologic examination could not be
ssessed due to associated head trauma. Given the inability to
ssess the patient’s symptoms of limb ischemia, an interven-
ion to revascularize the left subclavian artery was felt to be
arranted. Our institutional guidelines for the evaluation of
he absolute and relative indications for left subclavian artery
lar aortic repair (TEVAR) in a patient 9 hours after
into the left chest.B,Completion angiogram following
onstrates containment of the aortic rupture.
able IV. Hospital complications: endovascular and
pen repair
alue TEVAR Open P
26 49
ean intensive care unit
stay (hours) 471  864a 389  412 .581
Range 0-4315 17-1825
ength of stay (days) 30.1  48.7a 25.2  22.5 .558
Range 2-249 1-97
omplications
Multisystem organ
failure 1 (4%) 7 (14%) .249
Pneumonia 12 (46%) 31 (63%) .220
Pulmonary embolus 0 (0%) 2 (4%) .541
Tracheostomy 0 (38%) 15 (31%) .608
Renalb 1 (4%) 15 (31%) .007
Cerebrovasular accident 2 (8%) 3 (6%) 1.000
Paralysis/paraparesis 0 (0%) 3 (6%) 0.547
Recurrent laryngeal
nerve injury 0 (0%) 5 (10%) 0.157
Urinary tract infection 2 (8%) 13 (27%) 0.070
Bacteremia 4 (15%) 10 (20%) 0.759
Deep venous thrombosis 3 (12%) 5 (10%) 1.000
EVAR, Thoracic endovascular aortic repair.
n  24; time of injury, duration in intensive care unit, and length of stay
ata incomplete on two TEVAR patients.
Acute renal failure or insufficiency in the absence of multisystem organ
ailure.vascu
sationevascularization have been previously described.14 The final
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November 20121278 Riesenman et alpatient developed progressive hypertension and was found to
have a kink in the midportion of his endograft leading to a
pseudocoarctation 4 years after TEVAR. The patient’s history
was significant for an aborted attempt at open repair prior to
transfer to our institution. The transferring surgeon had ex-
ternally wrapped the aorta with Dacron, which created an
abrupt angulation in the aortic arch contributing to the defor-
mity appreciated in the endograft several years later. This was
successfully treated with a Palmaz stent.
For our TEVAR patients who underwent treatment for
acute blunt TAIs, our current practice is to perform CT
imaging at 1, 6, and 12months and then annually for the first
5 years. In patients who have demonstrated endograft stability
over this time, a more extended imaging interval is employed
to reduce the lifetime radiation exposure.No standard follow-
up imaging protocol is followed for patients who have under-
gone open repair. No endoleaks were detected on
follow-up imaging, although eight (35%) of the 23 endovas-
cular patients who survived to discharge were lost to follow-
up. Of the 38 open surgical patients who survived to dis-
charge, 11 had CT scans performed30 days after repair for
various indications. The only abnormality noted on these
studies was a left subclavian artery occlusion in an asymptom-
atic patient. No graft abnormalities were appreciated.
DISCUSSION
TEVAR has emerged as a less invasive form of treat-
ment that rapidly stabilizes the aortic injury and minimizes
the physiological stress to the trauma patient. Indeed, this
form of treatment has rapidly become the preferred treat-
ment modality for TAIs. Our institution began routinely
offering TEVAR for thoracic aortic pathologies in 2003,
and TEVAR was largely performed in parallel with open
surgery for acute TAIs since that time. During this TEVAR
era (2003), 25 patients underwent open surgical repair,
and the last was performed in October of 2007 represent-
ing our shift toward TEVAR as the preferred form of
treatment. Other authors have reported similar trends in
intervention preference. Moainie et al reported on their
institutional series of TEVAR for acute TAIs from the
University of Maryland over a 2-year time frame that oc-
curred shortly after the first commercially manufactured
thoracic endograft became available.7 During this time
period, 26 of 27 patients treated for TAIs underwent
TEVAR, with the one patient undergoing open repair due
to anatomic limitations. In an analysis of the National
Inpatient Sample database, Hong et al reported that
TEVAR comprised 67% of the interventions for TAI from
2006 to 2007.4 Additionally, it was noted that the total
number of interventions for TAI had increased following
commercial thoracic endograft availability and that these
endovascular patients were more severely injured, suggest-
ing that thoracic endograft availability has extended treat-
ment to patients previously considered not be candidates
for an intervention. In the multicenter prospective Ameri-
can Association for the Surgery of Trauma trial published in
2008 (AAST 2), 65% of patients in this study of TAIs
received stent grafts as their form of intervention, further gonfirming this early shift to TEVAR as the preferred form
f therapy among major trauma centers.9
Despite the preference of TEVAR over conventional
pen repair for acute TAIs, the potential benefits of this
orm of intervention remain controversial.17 Several com-
arative studies have demonstrated a significant overall
urvival advantage in favor of TEVAR as was observed in
ur series.4,9,18,19 In the most thorough literature review
o date, Murad et al reviewed 139 studies comprising 7768
atients treated for thoracic aortic transections.20 The au-
hors found a significant advantage in mortality for patients
ho underwent TEVAR compared with open surgery, and
ignificantly less spinal cord ischemia and renal injury, as
ell as graft and systemic infections. The limitations of the
tudy, and the resulting low quality of evidence to support
hese observations, were acknowledged by the authors and
eflect the difficulty with attempts to study a relatively rare
ondition in the acute setting. Despite these limitations,
his study served as the basis for the recently published
ociety for Vascular Surgery’s (SVS) clinical practice guide-
ines for the management of traumatic TAIs.21 Among
hese guidelines was the recommendation that TEVAR be
erformed preferentially over open surgical repair or non-
perative management. The mortality benefit observed in
ur series is consistent with these observations in the liter-
ture and further supports the SVS’s position on the issue.
Spinal cord ischemia (SCI) is a well-known complica-
ion associated with open surgical repair for acute
AIs.22,23 Modern management and refinements in car-
iovascular operative techniques have reduced the poten-
ial for this complication as illustrated by the reduction in
rocedure-related paraplegia for open surgical patients
8.7% vs 2.9%) between the 10-year time interval of the
ulticenter AAST 1 and AAST 2 trials.9,22 Although this
omplication was largely unobserved following TEVAR in
arly case series of TAIs,5 the systemic review by Murad et
l reported an event rate of 3% for this form of interven-
ion.20 In the present series, we did not observe this com-
lication following TEVAR, but SCI was observed in three
6%) of the open surgical operative survivors. In two of three
f these patients, the clamp-and-sew technique was utilized
ithout left heart bypass; a technique that has been associated
ith postoperative paraplegia.22 The observed SCI rate was
elatively low among the open surgical survivors despite a
ean cross-clamp time of 57minutes, which is in excess of the
eported threshold of 30 minutes associated with this compli-
ation.22,24 It is possible that the high intraoperativemortality
ate may have censored patients who would have sustained
his complication had they survived.
Abdominal endograft components had been com-
only utilized in the early experience with the treatment of
AIs due to a lack of commercially available thoracic de-
ices. Even with United States Food and Drug Administra-
ion approval of the Gore TAG in March of 2005, the
pplication of this device was limited by sizing constraints.
he subsequent arrival of two additional commercially
anufactured thoracic endografts to the U.S. market
reatly expanded treatment options, and currently available
(
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Volume 56, Number 5 Riesenman et al 1279off-the-shelf device configurations allow for the treatment of
thoracic aortic lesions with diameters ranging from 18mm to
42 mm based on the manufacturer’s instructions for use.6,14
Upuntil recently, noneof the currently commercially available
thoracic endografts were approved for the treatment of acute
TAIs. The continued practice of off-label use, or clinical trial
enrollment, remained the only way patients could receive this
form of intervention. Among the current designed en-
dografts, only one has been re-engineered with the intent to
treat younger patients that have characteristically higher aortic
velocities25 and small aortic diameters (Fig 2).
The recent SVS clinical guidelines recommend urgent
repair (24 hours) of these aortic injuries unless prohibi-
tive due to concomitant traumatic injuries. Furthermore,
these guidelines recommend expectant management and
serial imaging for patients with grade I or minimal aortic
injuries. Nonoperative medical management was success-
fully employed in these patients with grade I injuries, and
follow-up imaging identified one patient who went on to
develop a pseudoaneurysm at 6 months. Our experience
with this patient would support the need for early close
follow-up among the nonintervention subset of TAI pa-
tients. We routinely employ delayed repair in patients who
required stabilization of associated injuries; otherwise,
TEVAR is performed emergently for patients with grade II
and III, or IV injuries based on the anatomic classification
detailed by Azizzadeh et al.13 The importance of an expe-
dient intervention is illustrated by two of the patients
who died from aortic rupture. One patient expired follow-
ing a delay in transfer to our institution, and the second
Fig 2. Three-dimensional reconstruction of computed tomo-
graphic images of the thoracic aorta 1 month following thoracic
endovascular aortic repair (TEVAR) with a CTAG device for an
acute blunt thoracic aortic injury.patient expired following a significant institutional delay w2 hours) to intervention for his thoracic aortic injury.
mprovements in state-wide and institutional triage may
ave altered the outcomes in these patients.
Starnes et al reported on an alternative classification
cheme based on contour abnormalities of the aorta.26 The
ntimal tear (10 mm in length or width) and large intimal
ap (10 mm in length or width) injury classifications are
asically subgroups of the grade I (intimal tear) injuries de-
cribed by Azizzadeh et al.13 Interestingly, although Azizza-
eh et al described successful medical management of all
atients within this more inclusive grade I intimal tear classi-
cation, Starnes et al reported operative interventions on
atients within both subgroups of their intimal injury classifi-
ation. At this time, it is unclear if patients presenting with
hese large intimal flaps represent an anatomic subgroup at
igher risk for radiographic progression compared with pa-
ients with the more limited intimal tears. Additionally,
hether or not these patients warrant a more aggressive
ollow-up or tendency toward intervention remains to be
efined. The classification scheme by Starnes et al does not
tilize the grade II (intramural hematoma) category detailed
y Azizzadeh et al, with the reasoning that this radiographic
ndingmay be a consequence of injuries sustained to adjacent
tructures. Although we agree that this radiographic finding
ay lack specificity for blunt TAIs, at this time, not enough is
nown to forgo the recommendation to consider intervention
onsistent with the clinical practice guidelines outlined by the
VS.21
The need for secondary procedures is common follow-
ng TEVAR. In our series, 19% of patients underwent
econdary interventions in follow-up, which is consistent
ith the 20% device-related complication rate reported in
he AAST 2 trial (20%)9 but greater than the secondary
rocedure rate of 5.4% reported in the literature review by
urad et al.20 Three of these patients underwent secondary
rocedures as a result of malapposition to the inferior curve of
he aortic arch. Two of these patients had received abdominal
ndograft components early in our series, and the other had
eceived a TAG endoprosthesis. Malapposition and device
ollapse are potential complications when this thoracic en-
ograft platform is used to treat acute blunt TAIs.27 One
ould anticipate that the development of next-generation
horacic devices may reduce the rate of early and midterm
evice-related complications that have been observed in these
arly series. A lack of long-term follow-up with this form of
epair is largely absent at this time, precluding assessments of
urability. Unfortunately, when a sufficient time interval has
assed, the long-term behavior of these abdominal endograft
omponents and early-generation thoracic endografts may
ot be reflective of currently available thoracic devices, as well
s devices undergoing clinical trials.
Our study has many of the limitations inherent to similar
omparative institutional series on this topic.17 There was no
andomization or defined protocol for referring patients for
EVAR or open surgical intervention, and the patient popu-
ation was heterogeneous with respect to associated traumatic
njuries. Furthermore, within the TEVAR group, there was a
ide variety of endografts utilized. The rarity of this condition
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1
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November 20121280 Riesenman et alnecessitated a long study period (20 years) in order to make a
comparative analysis. This resulted in approximately 58% (n
35) of the open surgical patients having undergone their
procedure before some form of thoracic endovascular inter-
ventionwas available at our institution. These pre-TEVAR era
(1990-2002) open surgical patients may have had more ben-
eficial outcomes if managed with more recent medical inno-
vations. Interestingly, despite these advancements, the hospi-
tal mortality rate for open surgical patients was unchanged
when comparing the pre-TEVARand post-TEVAReras (37%
vs 36%; P 1.000).
CONCLUSIONS
Acute blunt TAI to the descending thoracic aorta is
associated with a high hospital mortality. TEVAR of these
injuries has advantages in terms of intraoperative and hos-
pital mortality when compared with conventional open
surgical repair. Additionally, TEVAR is associated with
reductions in operative time, blood loss, and intraoperative
blood transfusions compared with open surgical repair.
Given these benefits, TEVAR should be considered the
primary form of treatment for anatomically acceptable pa-
tients requiring intervention for their aortic injuries.
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